Trava Health’s promise of straightforward pricing sits alongside subscription terms that deserve a separate reading. The homepage says there are no hidden fees or membership traps, but the agreement permits automatic recurring charges and requires cancellation at least 48 hours before renewal processing. An additional boundary applies once an order has been transmitted to and processed by the pharmacy: it cannot be canceled, changed or refunded. Those are different deadlines, and stopping future payments does not necessarily unwind an existing order.
This review examines Trava’s public documentation consulted October 19, 2026, with particular attention to what a customer agrees to buy, who provides the care and when financial obligations become difficult to reverse. The documented service includes online intake, prescription review, injectable semaglutide and tirzepatide offerings, pharmacy fulfillment and ongoing support. Its terms currently limit availability to people located in Texas. Several price and entity details remain unresolved, so the practical task before enrollment is obtaining a written, patient-specific explanation rather than treating a headline price as the complete agreement.
At a glance
- Current service geography
- The terms limit service to people located in Texas who meet the stated adult age requirement; consultations must occur in the same state as the account’s shipping address.Sources: [5]
- Published injectable prices
- The homepage advertises semaglutide injections as low as $88.65 and tirzepatide injections as low as $147.33 without a period in those blocks. Product pages separately show $117.96 monthly and $178.98 monthly, respectively.
- Renewal deadline
- Subscription charges recur until cancellation. Cancellation must be requested at least 48 hours before the applicable renewal processing date and takes effect at the end of the current period.Sources: [5]
- Refund boundary
- Orders transmitted to and processed by the pharmacy cannot be canceled, modified or refunded. Partially used subscription periods are not refundable.Sources: [5]
Start with the two cancellation clocks
The most consequential contract distinction is between ending a subscription and canceling a pharmacy order. Trava’s agreement allows cancellation through the service, an online account, an email request or a call to 281-241-9005. The request must arrive at least 48 hours before the applicable renewal processing date, and cancellation takes effect at the end of the current subscription period. A customer should therefore identify the processing date itself, not assume it is interchangeable with a delivery date or calendar-month anniversary.
Separately, the agreement says an order cannot be canceled, modified or refunded once it has been transmitted to and processed by the pharmacy because the medication has already been prepared or dispensed. That wording makes order status important even if the package has not shipped. Trava also excludes refunds for partially used subscription periods. Limited exceptions may be reviewed before pharmacy processing, but they remain discretionary rather than a promised refund entitlement.
The useful enrollment question is not simply, “Can I cancel?” It is, “When will my next renewal process, when will my order reach pharmacy processing, and how will you confirm my request?” Our guide to cancellation notice and order status explains why these milestones should be recorded separately. Trava’s published rules provide a deadline, but the consulted documentation does not establish how much advance visibility customers receive into each pharmacy-processing event.
| Event | Published rule | What to establish before paying |
|---|---|---|
| Subscription renewal | Automatic charges continue until cancellation. | The processing date and billing interval shown at checkout. |
| Cancellation request | At least 48 hours before renewal processing; effective at period end. | The request channel and confirmation procedure. |
| Pharmacy processing | A transmitted and processed order cannot be canceled, changed or refunded. | How order status is communicated. |
| Partially used period | No refund for the unused portion. | What remains available through the period’s end. |
| Optional pause | Charges resume automatically after the pause unless canceled. | The pause end date and next charge date. |
The advertised prices do not yet make a complete quote
Trava’s homepage lists injectable semaglutide “As Low As $88.65” and injectable tirzepatide “As Low As $147.33.” Those product blocks do not state the supply period or the conditions required for the minimum. The separate semaglutide page displays $117.96 monthly, while the tirzepatide page displays $178.98 monthly. Neither consulted excerpt clearly ties that displayed monthly amount to a selected strength or presentation. These are documented prices, but not interchangeable promises about what every enrollee will pay.
The product pages also advertise quarterly-package savings: $87.92 for semaglutide and $94.96 for tirzepatide. The general pricing page says the quarterly option can save up to 33%. Those are Trava’s commercial claims; the consulted material does not show the corresponding quarterly totals or enough selected-product detail to reconcile all figures. Trava explains that price depends on the medication and strength prescribed, with lower strengths typically costing less. There is no basis here for assuming a fixed price through later prescription changes.
Before authorizing payment, ask for the exact injectable formulation, prescribed presentation, amount supplied, billing interval and total charge, including the next renewal. The documentation does not identify added ingredients or the formulation assigned to an individual patient. A written GLP-1 quote is particularly useful here because it can connect the prescription-specific price with the plan actually selected. Neither the homepage minimum nor a stated quarterly saving establishes an introductory offer, a universal rate or a minimum contractual commitment.
What the monthly and quarterly plans actually promise
The pricing page describes the monthly plan as paying one month at a time and receiving one month of medication at a time. It presents this as a lower-upfront-cost option with less long-term commitment. The quarterly plan provides three months of medication at a time, with fewer recurring payments and orders. That description identifies the intended medication period, but it does not specify vial count, package configuration or a separate minimum enrollment term. The selected checkout still needs to establish the actual payment arrangement.
Trava advertises free doctor consultation, free ongoing dedicated support, free next-day shipping and no add-on fees. Its terms say the total subscription price includes applicable charges for the platform, pharmacy medication and medical-group services. The homepage similarly says the displayed price is the price paid. These statements support an included-service model, but prescription-dependent pricing still matters. The next-day shipping claim does not identify its starting point or establish a guaranteed date of receipt following enrollment.
A pause is not the same as cancellation. The agreement says Trava may offer a temporary subscription pause, after which charges automatically resume unless the customer cancels before it ends. Customers considering that option should obtain the pause duration, restart date and next charge in writing. Our explanation of billing intervals and commitments helps separate a plan’s payment schedule from its supply period and termination rules. Trava’s plan descriptions should be read alongside, not instead of, the recurring-payment language.
Identify the company and the actual clinical provider
Trava’s terms identify the platform operator as Trava Health, Inc. and/or its subsidiaries. Its privacy policy instead uses Trava Health, LLC and affiliates. The documents do not explain whether these names reflect related entities, different functions or another arrangement. This discrepancy does not establish misconduct, but it leaves a basic contracting question unresolved: which legal entity is accepting payment, maintaining the account and responsible for responding to a billing or privacy request?
The clinical names also differ across documents. The homepage presents Wasef Health Partners and lists five physicians: Constantin Chikando, MD, in emergency medicine, and James Teet, DO, Michael Wasef, MD, David Wasef, MD, and Andrew Sakla, DO, in internal medicine. The agreement instead lists several You Health medical groups, including You Health of Texas. It also includes Beluga Health and GoGoMeds in its footer without fully explaining their roles. These listings are not independent verification of credentials or participation.
Most importantly, the agreement says Trava itself is not a healthcare provider and that a clinical relationship may arise with the medical group or individual providers. Ask which organization and clinician will conduct the consultation, hold the clinical record and handle treatment concerns. A clear map of platform, clinician and pharmacy responsibilities can keep a billing dispute from being confused with a prescribing question. The number of named organizations makes that division of responsibility more important, not less.
Enrollment is a consultation pathway, not a prescription guarantee
Trava describes a fully online medical intake covering health history, lifestyle and goals. It says licensed, board-certified providers review each intake; those claims were not independently verified for this review. The agreement makes the prescribing boundary clearer: a customer must complete a consultation, the provider must determine that the prescription product is appropriate, and the provider must issue a prescription. Completing a questionnaire or choosing a paid plan therefore should not be read as a guaranteed medication approval.
The agreement currently restricts service to individuals located in Texas who are at least 18, or the age of majority in their jurisdiction of residence if higher. During consultation, the customer must be in the same state as the shipping address in the account. The agreement’s separate exception for ages 13–18 concerns topical acne consultations with parental consent; it does not establish GLP-1 access for minors. Lists of medical groups from other states do not override the stated Texas availability restriction.
The consulted documentation does not specify GLP-1 BMI criteria, required laboratory testing, comorbidity requirements or detailed clinical exclusions. It also requires customers to supply compatible equipment, a video camera and internet access at their own expense, without establishing that every consultation necessarily uses video. Before paying, clarify what happens financially if the clinician declines to prescribe and whether additional assessment is needed. The published material does not supply a complete answer to that enrollment-and-refund scenario.
Pharmacy choice changes who collects the medication payment
The agreement lists Postmeds, Inc., doing business as TruePill; EHT Pharmacy LLC, doing business as Curexa; Apostrophe Pharmacy LLC; and XeCare LLC as prescription-fulfillment pharmacies. The homepage says Trava works with state-licensed pharmacies that compound and dispense under applicable law and USP standards. Those are provider representations, not independent quality findings. The consulted documentation does not identify which pharmacy fills a particular semaglutide or tirzepatide prescription, so customers should request that information before the order becomes nonrefundable.
Trava’s agreement also contemplates an outside pharmacy. It says the service will send a prescription to the selected pharmacy, but the customer must obtain the medication and pay that pharmacy directly. That is a material exception to assuming every medication cost sits inside the platform’s displayed total. Anyone choosing this route should ask how the Trava charge changes, what services remain included and whether the receiving pharmacy can fulfill the exact prescription. The documents do not settle those pricing details.
The terms additionally warn that prescriptions fulfilled by the listed pharmacies do not use child-resistant packaging. Shipping documentation leaves other practical questions open, including refrigeration arrangements, tracking and replacement for a lost shipment. FDA advises not using an injectable GLP-1 medication that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. That advice is separate from Trava’s refund policy: a delivery-quality concern should not be treated merely as a routine change-of-mind cancellation.
Included support is not a documented clinical timetable
Trava advertises online access to a care team, follow-ups, adjustments and answers when needed. It also says its team responds within 24 hours to matters ranging from refill questions to dose adjustments. That is a support-response claim, not a published guarantee that a prescribing decision, clinical review or pharmacy order will be completed within 24 hours. The consulted documents do not establish a separate clinical-review deadline or a defined routine follow-up schedule.
The agreement further says Trava or its providers may reach out for updated information and to facilitate ongoing subscriptions, but are not required to do so. Automatic payment therefore should not be mistaken for a promise of proactive reassessment before every renewal. Ask how treatment questions reach the prescribing clinician, when updated information is required and what happens to billing while a clinical question is unresolved. NIDDK describes follow-up as evaluating response and tolerance, not simply continuing medication payments.
Privacy terms deserve a place in this preparation. The agreement warns that HIPAA may not apply to particular transactions or communications involving the service and participating organizations. The privacy policy permits requesting a medical-record copy by email and says that doing so constitutes agreement to receive it unencrypted. Neither statement means all information is unprotected, but customers should clarify available secure communication and record-delivery options. The consulted documentation also does not confirm Spanish-language care or interpreter access.
Payment acceptance and product claims need separate verification
Trava advertises acceptance of HSA/FSA cards, but that payment option does not establish an individual expense’s eligibility. Its agreement says Trava and the medical groups do not participate in federal or state healthcare programs, including Medicare and Medicaid. The consulted documentation does not confirm private-insurance coverage or prior-authorization assistance. These are distinct questions: accepting a payment card, participating in a health plan and having a particular medication covered should not be treated as equivalent.
Trava discloses that compounded medicines require prescriptions, are not FDA approved and have not been evaluated by FDA for safety and effectiveness. It also says a prescriber must determine that the compounded preparation makes a significant difference for the patient compared with an approved product. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug. Nonapproval alone does not prove clinical inequivalence, but neither platform enrollment nor pharmacy participation establishes FDA approval.
The homepage’s phrase “Quality tested in the USA by FDA labs” remains an advertising claim, not independent verification or evidence of product approval. The documentation does not resolve the exact formulation, added ingredients or assigned pharmacy for an individual order. Contract clarity cannot establish clinical outcomes, and results from trials of specific studied products do not establish Trava-specific results. Before committing, the useful questions concern both the prescribed preparation and the organization accountable for explaining its selection.
Questions & answers
Does canceling Trava stop an order that has not arrived?
Not necessarily. Subscription cancellation ends future participation at the current period’s end, subject to the 48-hour notice deadline. An order already transmitted to and processed by the pharmacy cannot be canceled, modified or refunded under the agreement. Arrival is not the relevant cutoff; ask for the order’s actual pharmacy-processing status.
Which Trava price should I expect to pay?
The documentation does not establish one universal price. Homepage injectable minimums are $88.65 for semaglutide and $147.33 for tirzepatide without a stated period in those blocks. Product pages show $117.96 monthly and $178.98 monthly. Trava says medication and prescribed strength affect price; request the selected plan’s complete quote.
Can someone outside Texas enroll because the agreement names other states?
The consulted availability clause currently limits service to people located in Texas. It also requires the consultation location to match the state of the shipping address. References to medical groups in other states do not confirm access there. Confirm current availability directly before submitting payment or relying on a listed organization’s name.
Does Trava’s quarterly plan require a particular number of vials?
The pricing page says the quarterly plan provides three months of medication at a time. It does not establish vial count, exact presentation or the total quarterly price in the consulted excerpts. Ask for those details along with storage instructions and the renewal charge. A three-month medication period alone does not establish a minimum enrollment term.
Who should handle a prescription question versus cancellation?
Trava says clinical care belongs to the medical group or provider, not the platform itself. Ask which clinician and organization are responsible for your prescription. Cancellation can be requested through the service, an online account, email or 281-241-9005. The advertised 24-hour team response does not establish a clinical decision deadline.
Can I fill a Trava prescription at another pharmacy?
The agreement permits sending a prescription to a selected outside pharmacy. You would then be responsible for obtaining the medication and paying that pharmacy directly. Before choosing this option, ask what Trava itself will charge and whether any included medication charge changes. The public documentation does not resolve that adjustment.
Our assessment
Trava documents a recognizable online prescribing and fulfillment pathway, with monthly and quarterly medication plans, advertised included consultation and support, and several cancellation channels. Its main contractual trade-off is that recurring billing continues until properly canceled while pharmacy processing creates a separate, firm refund boundary. The unresolved prescription-specific prices and inconsistent company and clinical-entity names warrant clarification before payment. A useful decision point is whether Trava can provide one coherent written account of the exact product, total charge, renewal date, pharmacy cutoff and responsible clinical organization. Clear answers would improve financial and service transparency; they would not by themselves establish treatment suitability or clinical results.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Trava Health — policy/terms of service ↗
- Trava Health — policy/privacy policy ↗
- Trava Health — official website ↗
- Trava Health — products/semaglutide ↗
- Trava Health — pricing ↗
- Trava Health — products/tirzepatide ↗